Catherine Carroll - Cannabis Sativa CFO, Treasurer and Director
| CBDS Stock | USD 0.05 0.02 63.21% |
Director
Ms. Catherine Carroll serves as Director of the Company. She was Chief Financial Officer of the Company. Ms. Carroll was selfemployed since 1984 as a tax consultant and bookkeeper since 2017.
| Age | 82 |
| Tenure | 7 years |
| Phone | 702 763 3123 |
| Web | https://cannabissativainc.com |
Cannabis Sativa Management Efficiency
The company has return on total asset (ROA) of (0.2894) % which means that it has lost $0.2894 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5405) %, meaning that it created substantial loss on money invested by shareholders. Cannabis Sativa's management efficiency ratios could be used to measure how well Cannabis Sativa manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | DIRECTOR Age | ||
| Jeffrey Stellinga | iCoreConnect Common stock | 55 | |
| Chris Paalman | Healthcare Triangle | N/A | |
Management Performance
| Return On Equity | -0.54 | |||
| Return On Asset | -0.29 |
Cannabis Sativa Leadership Team
Elected by the shareholders, the Cannabis Sativa's board of directors comprises two types of representatives: Cannabis Sativa inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cannabis. The board's role is to monitor Cannabis Sativa's management team and ensure that shareholders' interests are well served. Cannabis Sativa's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cannabis Sativa's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Catherine Carroll, CFO, Treasurer and Director | ||
| David Tobias, Interim CEO and Director | ||
| Brad Herr, CFO Director | ||
| Carolyn Merrill, Controller |
Cannabis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Cannabis Sativa a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.54 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (0.56) % | |||
| Operating Margin | (0.79) % | |||
| Current Valuation | 1.2 M | |||
| Shares Outstanding | 44.87 M | |||
| Shares Owned By Insiders | 39.10 % | |||
| Price To Earning | (7.53) X | |||
| Price To Book | 1.86 X | |||
| Price To Sales | 1.15 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cannabis OTC Stock Analysis
When running Cannabis Sativa's price analysis, check to measure Cannabis Sativa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Sativa is operating at the current time. Most of Cannabis Sativa's value examination focuses on studying past and present price action to predict the probability of Cannabis Sativa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Sativa's price. Additionally, you may evaluate how the addition of Cannabis Sativa to your portfolios can decrease your overall portfolio volatility.